Sandra Mancilla Zamora Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups. Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Sandra Mancilla Zamora LinkedIn Twitter Orcid Email Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.
Degrees: Stable animal experimentation course. ABC function in 2020 Senior Clinical Analysis Technician in 2005 Higher Techniques in Pathological Anatomy and Cytology in 2001. Currently Vall d'Hebron University Hospital. VHIR-CIBBIM. FVPR since 01/11/2017 Technician in charge of the histology section of FVPR and the DDT group of the VHIR. With knowledge in environment and quality management at ISO 9001. Application management, internal positions… They also carry out research with various projects where I am in charge of the processing of the samples, making blocks, cuts, stains, immune. I give assistance the in vitro section (cell culture) and molecular biology techniques (western blot, enzymatic activities ...) and the in vivo section helping to prepare treatments, subcutaneous, intravenous cell inoculation, mammary, control of mice’s evolution, weight, tumor size, etc., necropsies and collection of biological samples for further processing. Responsible for the control of own equipment, maintenance, verification and calibration. Order control and organization of the general laboratory.
Projects Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT) IP: - Collaborators: José Antonio Arranz Amo, Raquel Barquin Del Pino, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Clara Ramírez Serra, Yolanda Villena Ortiz, Joan López Hellin, Albert Blanco Grau, Roser Ferrer Costa, Joaquin Seras Franzoso, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Laura Castillo Ribelles, Clara Carnicer Cáceres, Marina Giralt Arnaiz, Ana Gomez Garcia, Simon Schwartz Navarro, Pablo Gabriel Medina, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Laura Castellote Bellés, Daniel Bravo Nieto, Luz María Cruz Carlos, Clara Sanz Gea, Alba Estela García Fernández, Maria del Pilar Reimundo Diaz-Fierros, Belen Garcia Prats, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), JAUME VIMA BOFARULL, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Diana Fernandes de Rafael, Maria Francesca Cortese , Sandra Mancilla Zamora Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 01173 Duration: 01/01/2022 - 30/06/2025 Impacto y valor pronóstico de vesículas extracelulares tumorales provenientes de células madre cancerígenas en tumores de mama triple negativo. IP: Joaquin Seras Franzoso Collaborators: Laura García Latorre, Esther Zamora Adelantado, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Belen Garcia Prats Funding agency: Instituto de Salud Carlos III Funding: 99220 Reference: PI22/01301 Duration: 01/01/2023 - 31/12/2026 Vesículas extracelulares para el tratamiento de enfermeades lisosomales (Título provisional) IP: Zamira Vanessa Diaz Riascos Collaborators: Laura García Latorre, Guillem Pintos Morell, Sandra Mancilla Zamora, Marc Miquel Moltó Abad Funding agency: Instituto de Salud Carlos III Funding: 153670 Reference: PI21/00936 Duration: 01/01/2022 - 30/06/2025 NanoDIRE-CT - Uso de nanobodies para terapia dirigida contra células madre tumorales IP: - Collaborators: Simon Schwartz Navarro, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Diana Fernandes de Rafael Funding agency: Ministerio Ciencia, Innovación y Universidades Funding: 322172.61 Reference: RTC2019-006809-1 Duration: 01/09/2020 - 31/12/2023 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Page 4 Next page › Last page »
